Skip to main content

Elevance Health (ELV) Receives a Buy from Bernstein

Tipranks - Tipranks - Wed Jan 28, 6:56AM CST

Bernstein analyst Lance Wilkes maintained a Buy rating on Elevance Health today and set a price target of $431.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Wilkes is a 2-star analyst with an average return of 0.8% and a 50.00% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as CVS Health, Agilon Health, and Centene.

Elevance Health has an analyst consensus of Strong Buy, with a price target consensus of $396.17.

See the top stocks recommended by analysts >>

Based on Elevance Health’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $50.71 billion and a net profit of $1.19 billion. In comparison, last year the company earned a revenue of $45.15 billion and had a net profit of $1.02 billion

Read More on ELV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).